Jamila Michener, assistant professor of government, and Julilly Kohler-Hausmann, assistant professor of history, write in this New York Times opinion piece that tying Medicaid benefits to drug testing could imperil Medicaid's long-term viability and create a "vicious cycle of stigmatization and program retrenchment."
"This would tie lifesaving health care benefits to government procedures that force people to submit to degrading invasions of privacy," they write. "Of all the ways to help Americans with drug problems, threatening their Medicaid eligibility is among the worst options."
Read the entire New York Times piece here.
